Search

everythinglearnresearchcommunity

for

Search:↓

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Cancer prevention has advanced significantly, with some strategies proving successful.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Isotretinoin can raise CPK levels, so patients need monitoring, especially before surgery.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

A specific gene change plus an additional mutation in the same gene cause hereditary trichilemmal cysts.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Janus kinase inhibitors are effective and safe for treating alopecia areata.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

All-trans retinoic acid slows cell growth and increases cell death in goat hair follicles through a specific pathway.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.